Table 4.
Phthalate metabolite quartiles | N | Unadjusted OR (95% CI) | Confounder-adjusted† OR (95% CI) | Confounder- and female phthalate-adjusted‡ OR (95% CI) |
---|---|---|---|---|
MEP (ng/ml) | 211 | |||
1 (≤26.01) | 52 | 1.00 | 1.00 | 1.00 |
2 (26.02–57.07) | 53 | 0.85 (0.57 – 1.29) | 0.85 (0.56 – 1.29) | 0.92 (0.60 – 1.39) |
3 (57.08–140) | 53 | 1.02 (0.67 – 1.55) | 1.02 (0.67 – 1.55) | 1.16 (0.75 – 1.79) |
4 (141–15,634) | 53 | 1.10 (0.72 – 1.68) | 1.10 (0.72 – 1.68) | 1.29 (0.83 – 2.00) |
P-trend | 0.42 | 0.42 | 0.15 | |
MBP (ng/ml) | 199 | |||
1 (≤7.42) | 49 | 1.00 | 1.00 | 1.00 |
2 (7.43–13.74) | 50 | 0.73 (0.48 – 1.13) | 0.73 (0.47 – 1.13) | 0.66 (0.42 – 1.04) |
3 (13.75–23.13) | 51 | 0.81 (0.52 – 1.27) | 0.81 (0.52 – 1.27) | 0.66 (0.40 – 1.09) |
4 (23.14–4,756) | 49 | 0.85 (0.54 – 1.34) | 0.85 (0.54 – 1.34) | 0.69 (0.42 – 1.14) |
P-trend | 0.75 | 0.75 | 0.33 | |
MiBP (ng/ml) | 211 | |||
1 (≤4.33) | 51 | 1.00 | 1.00 | 1.00 |
2 (4.34–7.54) | 53 | 1.24 (0.82 – 1.88) | 1.25 (0.82 – 1.89) | 1.21 (0.78 – 1.87) |
3 (7.55–12.46) | 54 | 0.71 (0.47 – 1.07) | 0.71 (0.47 – 1.07) | 0.67 (0.43 – 1.06) |
4 (12.47–191) | 53 | 1.06 (0.70 – 1.61) | 1.06 (0.69 – 1.61) | 0.95 (0.58 – 1.54) |
P-trend | 0.96 | 0.96 | 0.70 | |
MBzP (ng/ml) | 211 | |||
1 (≤2.10) | 52 | 1.00 | 1.00 | 1.00 |
2 (2.11–4.06) | 53 | 0.70 (0.45 – 1.07) | 0.70 (0.45 – 1.07) | 0.70 (0.45 – 1.08) |
3 (4.07–7.02) | 53 | 0.73 (0.48 – 1.12) | 0.73 (0.48 – 1.12) | 0.78 (0.50 – 1.22) |
4 (7.03–176) | 53 | 0.66 (0.44 – 1.01) | 0.67 (0.44 – 1.01) | 0.69 (0.43 – 1.11) |
P-trend | 0.15 | 0.15 | 0.27 | |
MCPP (ng/ml) | 211 | |||
1 (≤2.31) | 53 | 1.00 | 1.00 | 1.00 |
2 (2.32–4.11) | 52 | 1.42 (0.98 – 2.05) | 1.43 (0.99 – 2.07) | 1.38 (0.94 – 2.01) |
3 (4.12–8.50) | 53 | 1.41 (0.94 – 2.13) | 1.42 (0.94 – 2.15) | 1.37 (0.88 – 2.12) |
4 (8.51–56.34) | 53 | 1.28 (0.84 – 1.96) | 1.29 (0.84 – 1.98) | 1.30 (0.82 – 2.07) |
P-trend | 0.56 | 0.55 | 0.58 | |
ΣDEHP (μmol/L) | 211 | |||
1 (≤0.119) | 51 | 1.00 | 1.00 | 1.00 |
2 (0.120–0.219) | 55 | 0.89 (0.60 – 1.34) | 0.89 (0.60 – 1.34) | 0.85 (0.55 – 1.30) |
3 (0.220–0.620) | 52 | 0.90 (0.60 – 1.36) | 0.90 (0.60 – 1.36) | 0.82 (0.53 – 1.28) |
4 (0.630–20.51) | 53 | 1.23 (0.80 – 1.89) | 1.23 (0.80 – 1.90) | 1.09 (0.67 – 1.78) |
P-trend | 0.14 | 0.14 | 0.31 | |
MCOP (ng/ml) | 190 | |||
1 (≤9.72) | 46 | 1.00 | 1.00 | 1.00 |
2 (9.73–24.43) | 49 | 0.85 (0.55 – 1.30) | 0.84 (0.55 – 1.30) | 0.86 (0.52 – 1.41) |
3 (24.44–71.10) | 48 | 0.94 (0.60 – 1.47) | 0.94 (0.60 – 1.47) | 1.07 (0.62 – 1.83) |
4 (71.11–813) | 47 | 0.87 (0.56 – 1.37) | 0.88 (0.56 – 1.38) | 1.05 (0.59 – 1.87) |
P-trend | 0.73 | 0.74 | 0.71 | |
MCNP (ng/ml) | 190 | |||
1 (≤2.75) | 47 | 1.00 | 1.00 | 1.00 |
2 (2.76–4.54) | 49 | 1.17 (0.77 – 1.77) | 1.17 (0.77 – 1.78) | 1.31 (0.83 – 2.08) |
3 (4.56–8.60) | 47 | 1.03 (0.67 – 1.58) | 1.03 (0.67 – 1.59) | 1.24 (0.77 – 1.99) |
4 (8.61–130) | 47 | 0.99 (0.64 – 1.53) | 0.99 (0.64 – 1.54) | 1.32 (0.79 – 2.20) |
P-trend | 0.69 | 0.69 | 0.74 |
Fertilization rate was defined as the number of fertilized oocytes with two pronuclei divided by the number of mature metaphase II oocytes
All models were adjusted for maternal age
These models were adjusted for maternal age and the female partner’s quartile of the phthalate of interest